1 - 10 out of 83Page size: 10
  1. 2023

  2. Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

    Garrelfs, S. F., Metry, E. L., van Harskamp, D., Vaz, F. M., van den Akker, C. H. P., Schierbeek, H., Groothoff, J. W. & Oosterveld, M. J. S., May 2023, In: Kidney international. 103, 5, p. 990-993 4 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. Endogenous oxalate production in primary hyperoxaluria type 1 patients

    Garrelfs, S. F., van Harskamp, D., Peters-Sengers, H., van den Akker, C. H. P., Wanders, R. J. A., Wijburg, F. A., van Goudoever, J. B., Groothoff, J. W., Schierbeek, H. & Oosterveld, M. J. S., 1 Dec 2021, In: Journal of the American Society of Nephrology. 32, 12

    Research output: Contribution to journal › Article › Academic › peer-review

  5. ANGPTL3 Inhibition with Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients with Homozygous Familial Hypercholesterolemia - Brief Report

    Reeskamp, L. F., Millar, J. S., Wu, L., Jansen, H., van Harskamp, D., Schierbeek, H., Gipe, D. A., Rader, D. J., Dallinga-Thie, G. M., Hovingh, G. K. & Cuchel, M., May 2021, In: Arteriosclerosis, thrombosis, and vascular biology. 41, 5, p. 1753-1759 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer

    Knottnerus, S. J. G., van Harskamp, D., Schierbeek, H., Bleeker, J. C., Crefcoeur, L. L., Ferdinandusse, S., van Goudoever, J. B., Houtkooper, R. H., IJlst, L., Langeveld, M., Wanders, R. J. A., Vaz, F. M., Wijburg, F. A. & Visser, G., Mar 2021, In: Clinical nutrition (Edinburgh, Scotland). 40, 3, p. 1396-1404 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Simultaneous assessment of intestinal permeability and lactase activity in human-milk-fed preterm infants by sugar absorption test: Clinical implementation and analytical method

    Mank, E., van Harskamp, D., van Toledo, L., van Goudoever, J. B. & Schierbeek, H., Mar 2021, In: Clinical nutrition (Edinburgh, Scotland). 40, 3, p. 1413-1419 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2020

  9. Milk protein oxidation in healthy subjects: A preliminary study

    Reckman, G. A. R., Koehorst, M., Schierbeek, H. & Vonk, R. J., 1 Dec 2020, In: International Dairy Journal. 111, 104826.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Development and validation of a gas chromatography–mass spectrometry method to analyze octanoate enrichments at low concentrations in human plasma

    van Harskamp, D., Knottnerus, S. J. G., Visser, G., van Goudoever, J. B. & Schierbeek, H., 1 Sept 2020, In: Analytical and bioanalytical chemistry. 412, 23, p. 5789-5797 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol

    Bouter, K. E. C., van Bommel, E. J. M., Jansen, H., van Harskamp, D., Schierbeek, H., Ackermans, M. T., Serlie, M. J., Schimmel, A. W. M., Nieuwdorp, M., Dallinga-Thie, G. M. & van Raalte, D. H., 1 Jun 2020, In: Diabetes, obesity & metabolism. 22, 6, p. 988-996 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial

    Kouwenhoven, S. M. P., Antl, N., Finken, M. J. J., Twisk, J. W. R., van der Beek, E. M., Abrahamse-Berkeveld, M., van de Heijning, B. J. M., Schierbeek, H., Holdt, L. M., van Goudoever, J. B. & Koletzko, B. V., 1 May 2020, In: American journal of clinical nutrition. 111, 5, p. 962-974 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. The 1-13C galactose breath test in GALT deficient patients distinguishes NBS detected variant patients but does not predict outcome in classical phenotypes

    Welsink-Karssies, M. M., van Harskamp, D., Ferdinandusse, S., Hollak, C. E. M., Huidekoper, H. H., Janssen, M. C. H., Kemper, E. M., Langendonk, J. G., Rubio-Gozalbo, M. E., de Vries, M. C., Wijburg, F. A., Schierbeek, H. & Bosch, A. M., 1 May 2020, In: Journal of inherited metabolic disease. 43, 3, p. 507-517 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 83018